C. Eheman, S. Henley, R. Ballard-barbash, E. Jacobs, M. Schymura et al., Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity, Cancer, vol.16, issue.suppl 2, pp.2338-66, 1975.
DOI : 10.1007/s10552-004-3487-5

W. Aih, Australian institute of health and welfare (AIHM) Cancer Aus Available from http, 1999.

B. Kohler, R. Sherman, N. Howlader, A. Jemal, A. Ryerson et al., Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State, JNCI: Journal of the National Cancer Institute, vol.158, issue.4, p.48, 2015.
DOI : 10.1016/j.cell.2014.06.049

M. Smyth, D. Godfrey, and J. Trapani, A fresh look at tumor immunosurveillance and immunotherapy, Nature Immunology, vol.163, issue.4, pp.293-302, 2001.
DOI : 10.1038/82771

C. Parish, Cancer immunotherapy: The past, the present and the future, Immunology and Cell Biology, vol.24, issue.1, pp.106-119, 2003.
DOI : 10.1097/00002371-200103000-00003

S. Rosenberg, Immunotherapy and gene therapy of cancer, Cancer Res, vol.51, pp.5074-5083, 1991.

S. Rosenberg, J. Yang, and N. Restifo, Cancer immunotherapy: moving beyond current vaccines, Nature Medicine, vol.88, issue.9, pp.909-924, 2004.
DOI : 10.1002/1097-0215(20001015)88:2<232::AID-IJC14>3.0.CO;2-8

URL : http://europepmc.org/articles/pmc1435696?pdf=render

M. Chi and A. Dudek, Vaccine therapy for metastatic melanoma, Melanoma Research, vol.21, issue.3, pp.165-74, 2011.
DOI : 10.1097/CMR.0b013e328346554d

A. Choudhury, S. Mosolits, P. Kokhaei, L. Hansson, M. Palma et al., Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future, Adv Cancer Res, vol.95, pp.147-202, 2006.
DOI : 10.1016/S0065-230X(06)95005-2

M. Atkins and M. Sznol, Cancer Immunotherapy: Past Progress and Future Directions, Seminars in Oncology, vol.42, issue.4, pp.518-540, 2015.
DOI : 10.1053/j.seminoncol.2015.05.001

W. Liu, T. Hillen, and H. Freedman, A mathematical model for m-phase specific chemotherapy including the g0-phase and immunoresponse, Math Biosci Eng, vol.4, issue.2, pp.239-59, 2007.

L. Kunz-schughart, M. Kreutz, and R. Knuechel, Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology, International Journal of Experimental Pathology, vol.62, issue.42, pp.1-23, 1998.
DOI : 10.1038/bjc.1990.266

F. Castiglione and B. Piccoli, Optimal Control in a Model of Dendritic Cell Transfection Cancer Immunotherapy, Bulletin of Mathematical Biology, vol.39, issue.4, pp.255-74, 2006.
DOI : 10.1007/s11538-005-9014-3

F. Castiglione and B. Piccoli, Cancer immunotherapy, mathematical modeling and optimal control, Journal of Theoretical Biology, vol.247, issue.4, pp.723-755, 2007.
DOI : 10.1016/j.jtbi.2007.04.003

S. Bunimovich-mendrazitsky, J. Gluckman, and J. Chaskalovic, A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer, Journal of Theoretical Biology, vol.277, issue.1, pp.27-40, 2011.
DOI : 10.1016/j.jtbi.2011.02.008

J. Folkman, Tumor angiogenesis: therapeutic implications, New Engl J Med, vol.285, issue.21, pp.1182-1188, 1971.

L. Holmgren, M. Oreilly, and J. Folkman, Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression, Nature Medicine, vol.218, issue.2, pp.149-53, 1995.
DOI : 10.1016/0022-3468(93)90246-H

G. Naumov, L. Akslen, and J. Folkman, Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch, Cell Cycle, vol.5, issue.16, pp.1779-87, 2006.
DOI : 10.4161/cc.5.16.3018

S. Indraccolo, Insights into the Regulation of Tumor Dormancy by Angiogenesis in Experimental Tumors, Adv Exp Med Biol, vol.734, pp.37-52, 2013.
DOI : 10.1007/978-1-4614-1445-2_3

Y. Shaked, S. Mcallister, O. Fainaru, and N. Almog, Tumor Dormancy and the Angiogenic Switch: Possible Implications of Bone Marrow- Derived Cells, Current Pharmaceutical Design, vol.20, issue.30, pp.4920-4953, 2014.
DOI : 10.2174/1381612819666131125153536

S. Benzekry, A. Gandolfi, and P. Hahnfeldt, A mathematical model of systemic inhibition of angiogenesis in metastatic development, ESAIM: Proceedings and Surveys, vol.45, pp.75-87, 2014.
DOI : 10.1051/proc/201445008

URL : https://hal.archives-ouvertes.fr/hal-00867992

I. Fidler, Timeline: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited, Nature Reviews Cancer, vol.3, issue.6, pp.453-461, 2003.
DOI : 10.1038/nrc1098

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011.
DOI : 10.1016/j.cell.2011.02.013

M. Oreilly, L. Holmgren, Y. Shing, C. Chen, R. Rosenthal et al., Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma, Cell, vol.79, issue.2, pp.315-343, 1994.
DOI : 10.1016/0092-8674(94)90200-3

M. Oreilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios et al., Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth, Cell, vol.88, issue.2, pp.277-85, 1997.
DOI : 10.1016/S0092-8674(00)81848-6

B. Al-husein, M. Abdalla, M. Trepte, D. Deremer, and P. Somanath, Antiangiogenic Therapy for Cancer: An Update, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.301, issue.26, pp.1095-111, 2012.
DOI : 10.1126/science.301.5638.1308

H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth et al., Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2377, 2004.
DOI : 10.1056/NEJMoa032691

B. Giantonio, P. Catalano, N. Meropol, O. Dwyer, P. Mitchell et al., Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200, Journal of Clinical Oncology, vol.25, issue.12, pp.1539-1583, 2007.
DOI : 10.1200/JCO.2006.09.6305

A. Sandler, R. Gray, M. Perry, J. Brahmer, J. Schiller et al., Paclitaxel???Carboplatin Alone or with Bevacizumab for Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.355, issue.24, pp.2542-51, 2006.
DOI : 10.1056/NEJMoa061884

P. Hahnfeldt, D. Panigrahy, J. Folkman, and L. Hlatky, Tumor development under angiogenic signaling a dynamical theory of tumor growth, treatment response, and postvascular dormancy, Cancer Res, vol.59, pp.4770-4775, 1999.

A. Ergun, K. Camphausen, and L. Wein, Optimal Scheduling of Radiotherapy and Angiogenic Inhibitors, Bulletin of Mathematical Biology, vol.65, issue.3, pp.407-431, 2003.
DOI : 10.1016/S0092-8240(03)00006-5

A. Donofrio and A. Gandolfi, Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999), Mathematical Biosciences, vol.191, issue.2, pp.159-84, 1999.
DOI : 10.1016/j.mbs.2004.06.003

Z. Agur, L. Arakelyan, P. Daugulis, and Y. Ginosar, Hopf point analysis for angiogenesis models, Discrete and Continuous Dynamical Systems - Series B, vol.4, issue.1, pp.29-38, 2004.
DOI : 10.3934/dcdsb.2004.4.29

URL : http://calvino.polito.it/%7Emcrtn/doc/lib/agur-arakelyan-etal-hopf-angiogenesis-dcds2004.pdf

U. Forys, Y. Kheifetz, and Y. Kogan, Critical-point analysis for three-variable cancer angiogenesis models, Math Biosci Eng, vol.2, issue.3, pp.511-536, 2005.

V. Kuznetsov, I. Makalkin, M. Taylor, and A. Perelson, Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis, Bulletin of Mathematical Biology, vol.2, issue.2, pp.295-321, 1994.
DOI : 10.1007/978-1-4757-4067-7

M. Owen and J. Sherratt, Modelling the macrophage invasion of tumours: Effects on growth and composition, Mathematical Medicine and Biology, vol.15, issue.2, pp.165-85, 1998.
DOI : 10.1093/imammb/15.2.165

J. Adam, The dynamics of growth-factor-modified immune response to cancer growth: One dimensional models, Mathematical and Computer Modelling, vol.17, issue.3, pp.83-106, 1993.
DOI : 10.1016/0895-7177(93)90041-V

R. Araujo and D. Mcelwain, A history of the study of solid tumour growth: the contribution of mathematical modelling, Bulletin of Mathematical Biology, vol.66, issue.5, pp.1039-91, 2004.
DOI : 10.1016/j.bulm.2003.11.002

M. Martins, S. Ferreira, and M. Vilela, Multiscale models for the growth of avascular tumors, Physics of Life Reviews, vol.4, issue.2, pp.128-56, 2007.
DOI : 10.1016/j.plrev.2007.04.002

T. Roose, S. Chapman, and P. Maini, Mathematical Models of Avascular Tumor Growth, SIAM Review, vol.49, issue.2, pp.179-208, 2007.
DOI : 10.1137/S0036144504446291

M. Chaplain, Modelling aspects of cancer growth: insight from mathematical and numerical analysis and computational simulation In: Multiscale problems in the life sciences, pp.147-200, 2008.

E. Shochat, D. Hart, and Z. Agur, USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS, Mathematical Models and Methods in Applied Sciences, vol.42, issue.9, pp.599-615, 1999.
DOI : 10.1002/1097-0142(19910115)67:2<421::AID-CNCR2820670217>3.0.CO;2-Q

J. Adam and J. Panetta, A simple mathematical model and alternative paradigm for certain chemotherapeutic regimens, Mathematical and Computer Modelling, vol.22, issue.8, pp.49-60, 1995.
DOI : 10.1016/0895-7177(95)00154-T

R. Martin, Optimal control drug scheduling of cancer chemotherapy, Automatica, vol.28, issue.6, pp.1113-1136, 1992.
DOI : 10.1016/0005-1098(92)90054-J

D. Pillis, L. Radunskaya, and A. , A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach, Journal of Theoretical Medicine, vol.3, issue.2, pp.79-89
DOI : 10.1080/10273660108833067

M. Greenblatt, W. Bennett, M. Hollstein, and C. Harris, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res, vol.54, issue.18, pp.4855-78, 1994.

A. Knudson, Mutation and Cancer: Statistical Study of Retinoblastoma, Proceedings of the National Academy of Sciences, vol.68, issue.4, pp.820-823, 1971.
DOI : 10.1073/pnas.68.4.820

M. Nowak, N. Komarova, A. Sengupta, P. Jallepalli, I. Shih et al., The role of chromosomal instability in tumor initiation, Proceedings of the National Academy of Sciences, vol.148, issue.4, pp.16226-16257, 2002.
DOI : 10.1016/0027-5107(92)90186-6

M. Bissell and W. Hines, Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression, Nature Medicine, vol.23, issue.3, pp.320-329, 2011.
DOI : 10.1200/JCO.2005.11.030

F. Nani and H. Freedman, A mathematical model of cancer treatment by immunotherapy, Mathematical Biosciences, vol.163, issue.2, pp.159-99
DOI : 10.1016/S0025-5564(99)00058-9

D. Pillis, L. Radunskaya, and A. , The dynamics of an optimally controlled tumor model: A case study, Mathematical and Computer Modelling, vol.37, issue.11, pp.1221-1265, 2003.
DOI : 10.1016/S0895-7177(03)00133-X

L. Viger, F. Denis, R. M. Letellier, and C. , A cancer model for the angiogenic switch, Journal of Theoretical Biology, vol.360, pp.21-33, 2014.
DOI : 10.1016/j.jtbi.2014.06.020

URL : https://hal.archives-ouvertes.fr/hal-01544737

D. Kirschner and J. Panetta, Modeling immunotherapy of the tumor - immune interaction, Journal of Mathematical Biology, vol.37, issue.3, pp.235-52, 1998.
DOI : 10.1007/s002850050127

N. Kronik, Y. Kogan, V. Vainstein, and Z. Agur, Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics, Cancer Immunology, Immunotherapy, vol.79, issue.151(1), pp.425-464, 2008.
DOI : 10.4049/jimmunol.167.9.5429

K. Chan, C. Koh, and H. Li, Mitosis-targeted anti-cancer therapies: where they stand, Cell Death & Disease, vol.76, issue.10, p.411, 2012.
DOI : 10.1038/sj.leu.2403649

URL : http://www.nature.com/cddis/journal/v3/n10/pdf/cddis2012148a.pdf

L. Viger, F. Denis, C. Draghi, T. Ménard, and C. Letellier, Spatial avascular growth of tumor in a homogeneous environment, Journal of Theoretical Biology, vol.416, pp.99-112, 2016.
DOI : 10.1016/j.jtbi.2016.12.011

URL : https://hal.archives-ouvertes.fr/hal-01611148

F. Igney and P. Krammer, Immune escape of tumors: apoptosis resistance and tumor counterattack, J Leukoc Biol, vol.71, issue.6, pp.907-927, 2002.

C. Drake, E. Jaffee, and D. Pardoll, Mechanisms of Immune Evasion by Tumors, Adv Immunol, vol.90, pp.51-81, 2006.
DOI : 10.1016/S0065-2776(06)90002-9

L. Chevalier and T. , Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?, Annals of Oncology, vol.25, issue.21, pp.196-198, 2010.
DOI : 10.1200/JCO.2007.13.9030

C. Zhou, Y. Wu, G. Chen, X. Liu, Y. Zhu et al., BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.33, issue.19, pp.2197-204, 2015.
DOI : 10.1200/JCO.2014.59.4424

C. Letellier, F. Denis, and L. Aguirre, What can be learned from a chaotic cancer model?, Journal of Theoretical Biology, vol.322, pp.7-16, 2013.
DOI : 10.1016/j.jtbi.2013.01.003

C. Letellier, L. Aguirre, and J. Maquet, Relation between observability and differential embeddings for nonlinear dynamics, Physical Review E, vol.170, issue.6, p.66213, 2005.
DOI : 10.1086/109234

M. Frunzete, J. Barbot, and C. Letellier, Influence of the singular manifold of nonobservable states in reconstructing chaotic attractors, Physical Review E, vol.22, issue.2, p.26205, 2012.
DOI : 10.1111/j.1749-6632.1980.tb29710.x

C. Letellier and L. Aguirre, Symbolic observability coefficients for univariate and multivariate analysis, Physical Review E, vol.4, issue.6, p.66210, 2009.
DOI : 10.1016/j.automatica.2007.02.010

E. Bianco-martinez, M. Baptista, and C. Letellier, Symbolic computations of nonlinear observability, Physical Review E, vol.91, issue.6, p.62912, 2015.
DOI : 10.1098/rspb.1995.0153

URL : https://hal.archives-ouvertes.fr/hal-01612374

F. Denis, L. Viger, A. Charron, E. Voog, O. Dupuis et al., Detection of lung cancer relapse using self-reported symptoms transmitted via an Internet Web-application: pilot study of the sentinel follow-up, Supportive Care in Cancer, vol.19, issue.11, pp.1467-73, 2014.
DOI : 10.1007/s00520-010-1014-7

URL : https://hal.archives-ouvertes.fr/hal-01612423

F. Denis, S. Yossi, S. Septans, A. Charron, A. Voog et al., Improving Survival in Patients Treated for a Lung Cancer Using Self-Evaluated Symptoms Reported Through a Web Application, American Journal of Clinical Oncology, vol.40, issue.5, 2015.
DOI : 10.1097/COC.0000000000000189

S. Nadal, I. Boccaletti, S. Letellier, and C. , Observability coefficients for predicting the class of synchronizability from the algebraic structure of the local oscillators, Physical Review E, vol.94, issue.4, p.42205, 2016.
DOI : 10.1098/rspb.1984.0024

URL : https://hal.archives-ouvertes.fr/hal-01611231

F. Denis and C. Letellier, Radiotherapy and chaos theory: the tit bird and the butterfly, Cancer Radiotherapie, vol.16, pp.5-6404, 2012.